Download Free Medical Management of Keloids PowerPoint Presentation

Management of Keloids PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Acne Scar Removal, which is titled "Management of Keloids", to know about keloids, non-cancerous fibrous proliferations that occur in the dermis after trauma or injury to the skin.

Tags : Acne Scar Removal, Management, dermis

Published on : Jul 05, 2021 | Views : 1954 | Downloads : 4

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Management of Keloids By: Thad Riley Advisor: Bill Grimes
Slide 2-

What is a Keloid? Non-cancerous fibrous proliferations that occur in the dermis after trauma or injury to the skin Keloids grow beyond the boundaries of the original wound site (vs. hypertrophic scar) Etiological factors that determine how a scar becomes a keloid remain unknown
Slide 3-

Who and Why? Individuals with darker-pigmented skin or who freckle are more predisposed Seen largely in Africans, African-Americans, Hispanics, and Asians Can be a familial/genetic predisposition Can be due to immunological causes Bottom line… No one knows!
Slide 4-

How? (Pathophysiology) A result of an overactive inflammatory response and fibroblast proliferation A result of an abnormal collagen deposition in healing skin wounds Skin wound tension is a contributing factor in keloid formation Individuals with an inflammatory or infectious element are at a predisposition for keloids
Slide 5-

Ready for the Pictures?
Slide 6-

Where? Anterior Chest
Slide 7-

Where? Mandibular angle
Slide 8-

Where? Shoulder
Slide 9-

Where? Earlobes
Slide 10-

Where? Upper Arms & Upper Back
Slide 11-

Where? Posterior Neck Lateral Neck
Slide 12-

So…What’s the Problem?
Slide 13-

The Problem PROBLEM is with the TREATMENT OPTIONS The pathophysiology of these scars is so poorly understood that it is basically unknown Surgery is the only approved treatment A successful surgical protocol for removal of these types of scars is greatly lacking Surgical treatments available today only provide temporary relief Often grow back and do so in an aggressive manner
Slide 14-

Possible Solutions Surgical excision alone Post-surgical treatment agents: Mitomycin C solution The dietary compound quercetin Imiquimod 5% topical cream Intralesional corticosteroid injection Topical silicone gel sheets
Slide 15-

How they work… Mitomycin C solution (MC) An anti-neoplastic agent Has anti-proliferative effects on fibroblasts, stopping keloid formation MC effectively blocks angiogenesis during the healing process of the wound, thus inhibiting keloid development MC is widely available and relatively cheap
Slide 16-

How they work… The dietary compound quercetin most common sources: apples, onions, red wine, and ginkgo biloba. has strong anticancer, antioxidant, antiviral, anti-inflammatory, and antimicrobial characteristics Inhibit keloid fibroblast proliferation, collagen production, and contraction of keloid derived fibroblasts
Slide 17-

How they work… Imiquimod 5% topical cream Induces apoptosis in keloidal tissue Intralesional corticosteroid injection Inhibit fibroblast growth and break down collagen deposition postoperative steroid injection is the most common form of keloid treatment corticosteroids commonly used include hydrocortisone and dexamethasone.
Slide 18-

How they work… Topical silicone gel sheets Impermeable to water, reduces hemostasis and therefore, decreases the hyperemia and fibrosis often associated with keloids have been used for more than twenty years to help reduce the size of scarring efficacy and safety of the silicone gel sheets is well established.
Slide 19-

And the Winner is… Imiquimod 5% topical cream
Slide 20-

Analysis 13 keloids from 12 patients were surgically removed All keloids were present for at least 1 year and free of any treatment for the past 2 months A thin layer of imiquimod 5% cream was applied topically each night for 8 weeks 4 week asessments At 24 weeks, no keloids had recurred Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids (Berman and Kaufman, 2002 )
Slide 21-

Analysis 2 cases of irritation and superficial erosion were reported; resolved with cessation of the cream At the 24 week assessment, RECURRENCE RATES of keloids treated with imiquimod 5% cream were LOWER than any previously reported in the literature Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids (Berman and Kaufman, 2002 )
Slide 22-

Analysis Study did not control for the effects of vehicle application or other potential variables Further comparative studies with longer follow-up periods are needed Additional studies needed to determine dosing frequency and duration Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids (Berman and Kaufman, 2002 )
Slide 23-

Conclusion To develop a successful treatment plan for the keloid, two things have to be done: 1. Further research to better understand the causes behind keloid formation 2. Establish a standard surgical protocol In short, the topic of keloids is greatly under-exposed.
Slide 24-

One More
Slide 25-

References Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol. 2002; 47: S209-11. Berman B, Villa A. Imiquimod 5% cream for keloid management. Dermatol Surg. 2003; 29: 1050-51. Fortunato NH, Berry EC, Kohn ML. Berry and Kohn’s Operating Room Technique. 10th ed. St. Louis: Mosby-Year Book, Inc; 2003. Gold MH, Foster TD, Adair MA, Burlison K, Lewis T. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg. 2001; 27: 641-44. Hom DB. Treating the elusive keloid. Arch Otolaryngol Head Neck Surg. 2001; 127(9): 1140-43. Jacob SE, Berman B, Nassiri M, Vincek V. Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis. Brit J Dermatol. 2003; 149(66): 62-5. Kumar V, Abbas AK, Fausto N. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Philadelphia: Elseiver Saunders, Inc; 2005. Phana TT, Lim IJ, Chan SY, Tan EK, Lee ST, Longaker MT. Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars. J Trauma. 2004; 57(5): 1032-37. Phanb TT, See P, Tran E, Nguyen TTT, Chan SY, Lee ST, Huynh H. Suppression of insulin-like growth factor signaling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids. Brit J Dermatol. 2003; 148: 544-52. Talmi YP, Orenstein A, Wolf M, Kronenberg J. Use of mitomycin C for treatment of keloid: a preliminary report. Otolaryngol Head Neck Surg. 2005; 132: 598-601. Way LW, Doherty GM. Current surgical diagnosis and treatment. 11th ed. New York: McGraw-Hill; 2003.